Clinical Trial Update: Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

View source ↗

Summary

Clinical trial NCT06706700 is evaluating endocrine, metabolic, and inflammatory biomarkers to identify high-grade dysplasia or invasive carcinoma in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm of the Pancreas
• Pancreatic Cyst

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Intraductal Papillary Mucinous Neoplasm of Pancreas, Pancreatic Cyst | Status: RECRUITING